Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02546622
What this trial is testing

ATHN 2: Factor Switching Study

Who this might be right for
Hemophilia
American Thrombosis and Hemostasis Network 310
Testing effectiveness (Phase 2)Study completedNCT00154492
What this trial is testing

Use of NovoSeven® in Active Variceal Bleeding

Who this might be right for
Acquired Bleeding DisorderCirrhosis
Novo Nordisk A/S 265
Not applicableLooking for participantsNCT07414511
What this trial is testing

Hemophilia A Research Program

Who this might be right for
Hemophilia AHemophilia A, SevereFactor VIII (FVIII)+10 more
University of Washington 500
Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Not applicableStudy completedNCT00417131
What this trial is testing

Imaging of Islet Transplantation With PET and MRT

Who this might be right for
Islet TransplantationDiabetes Type 1
Uppsala University Hospital 8
Post-approval studies (Phase 4)Study completedNCT01487837
What this trial is testing

Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

Who this might be right for
Blood Coagulation DisordersHemorrhage
University Children's Hospital, Zurich 57
Not applicableStudy completedNCT02796222
What this trial is testing

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Who this might be right for
Hemophilia A, CongenitalHemophilia B, Congenital
University of British Columbia 61
Not applicableStudy completedNCT02025764
What this trial is testing

The Clinical Feature of Ulcer Base Over Time After Prophylactic Argon Plasma Coagulation in Colonic EMR

Who this might be right for
Gastrointestinal Hemorrhage
Soonchunhyang University Hospital 40
Not applicableEnrolling By InvitationNCT04065516
What this trial is testing

ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia

Who this might be right for
AchalasiaGastroesophageal Reflux
Coordinación de Investigación en Salud, Mexico 44
Post-approval studies (Phase 4)Study completedNCT00586521
What this trial is testing

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

Who this might be right for
Hematologic DiseaseHemophilia A
Bayer 20
Not applicableStudy completedNCT02287649
What this trial is testing

Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 45
Not applicableLooking for participantsNCT06705829
What this trial is testing

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.

Who this might be right for
Hemorrhagic DisordersExtrinsic Pathway Factor DeficiencyHepatocellular Insufficiency With Coagulopathy
University Hospital, Strasbourg, France 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06078839
What this trial is testing

Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy

Who this might be right for
SepsisSepsis-induced CoagulopathyNafamostat Mesilate
Xu Li 778
Early research (Phase 1)Study completedNCT00922792
What this trial is testing

Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 8
Testing effectiveness (Phase 2)Ended earlyNCT05164471
What this trial is testing

Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Who this might be right for
Hemophilia B
Spur Therapeutics 6
Large-scale testing (Phase 3)UnknownNCT05328804
What this trial is testing

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Yin Jie 90
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Not applicableStudy completedNCT05617209
What this trial is testing

In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 20
Not applicableStudy completedNCT05425888
What this trial is testing

Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy

Who this might be right for
Haemophilia
Investigación en Hemofilia y Fisioterapia 32
Next Page